Results of a national UK physician reported survey of COVID-19 infection in patients with a myeloproliferative neoplasm.

Salisbury RA., Curto-Garcia N., O'Sullivan J., Chen F., Polzella P., Godfrey AL., Russell J., Knapper S., Willan J., Frewin R., Joshi S., Arami S., Burns S., Teh CH., Wadelin F., Dhanapal J., Neelakantan P., Milojkovic D., Psaila B., Szydlo R., Francis S., Cargo C., Jain M., McGregor A., Wallis L., Duncombe A., Hussein H., Dyer P., Munro L., Bond L., McMullin MF., Somervaille TCP., Garg M., Sekhar M., Harrison C., Mead AJ., Innes AJ.

DOI

10.1038/s41375-021-01143-2

Type

Journal article

Publication Date

2021-08-01T00:00:00+00:00

Volume

35

Pages

2424 - 2430

Total pages

6

Keywords

Adult, Aged, Aged, 80 and over, COVID-19, Disease Management, Female, Humans, Male, Middle Aged, Myeloproliferative Disorders, SARS-CoV-2, Survival Analysis, United Kingdom

Permalink More information Close